Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,456.00    -40.00 (-0.89%)
Bid:
4,440.00
Ask:
4,448.00
Spread: 8.00 (0.18%)
Market Cap: £2.08b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Director/PDMR Shareholding

21 Nov 2019 09:21

RNS Number : 2057U
Morgan Sindall Group PLC
21 November 2019
Β 

MORGAN SINDALL GROUP PLC

Β 

21 November 2019

Director Shareholding

Β 

Morgan Sindall Group plc (the Company) announces that it has been notified of the following transaction in the Company's ordinary 5p shares undertaken by John Morgan, Chief Executive.

Β 

On 20 November 2019, John Morgan exercised 106,364 share options which were granted to him under the rules of the Company's Executive Remuneration Plan 2005 on 17 March 2010 at an option price of Β£5.55 per share. These options were due to lapse on 16 March 2020 if not exercised. He subsequently sold these shares at a market price of Β£13.64 per share. John Morgan's interests in the ordinary shares of the Company are unchanged a result of this transaction at 4,284,519 shares.

Β 

The following notification is intended to satisfy the Company's obligations under Article 19.3 of EU Regulation No 596/2014 (the Market Abuse Regulation).

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

John Christopher Morgan

2

Β 

Reason for the notification

a)

Β 

Position/status

Chief Executive

b)

Β 

Initial notification /Amendment

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Morgan Sindall Group plc

b)

Β 

LEI

2138008339ULDGZRB345

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p

Β 

Β 

Identification code

GB0008085614

Β 

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Acquision of 106,364 at Β£5.55 per share following the exercise of share options granted in 2010 under Part B of the Morgan Sindall Executive Remuneration Plan 2005 and subsequent sale of 106,364 shares at Β£13.64 per share.

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Β 

Β 

Price(s)

Volume(s)

Β 

Β 

Β 

Β£13.64

106,364

Β 

Β 

Β 

Β 

Β 

Β 

d)

Β 

Aggregated information

N/a single transaction

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

e)

Β 

Date of the transaction

Β 

20 November 2019

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHLIFFALILLFIA
Date   Source Headline
4th Jun 202611:43 amRNSDirector/PDMR Shareholding
3rd Jun 202611:56 amRNSDirector/PDMR Shareholding
1st Jun 20269:27 amRNSTotal Voting Rights
27th May 20261:29 pmRNSAdmission to Trading
20th May 202611:35 amRNSIssue of Equity
7th May 202612:38 pmRNSResult of AGM
1st May 20261:33 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSTotal Voting Rights
20th Apr 20263:44 pmRNSHolding(s) in Company
16th Apr 20264:09 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSTrading and Outlook for 2026
14th Apr 20262:18 pmRNSAdmission to Trading
1st Apr 20269:53 amRNSTotal Voting Rights
26th Mar 20261:27 pmRNSHolding(s) in Company
24th Mar 202612:56 pmRNSAnnual Financial Report
20th Mar 202612:42 pmRNSIssue of Equity
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
4th Mar 20262:38 pmRNSDirector/PDMR Shareholding
4th Mar 20262:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:33 pmRNSIssue of Equity / Admission to Trading
2nd Mar 20269:22 amRNSTotal Voting Rights
26th Feb 20269:53 amRNSDirector Declaration
25th Feb 20267:00 amRNSResults for the Full Year ended 31 December 2025
12th Feb 20267:00 amRNSTrading and Outlook for 2026
2nd Feb 20269:13 amRNSTotal Voting Rights
19th Jan 20267:00 amRNSNotice of Full Year Results
2nd Jan 202611:09 amRNSTotal Voting Rights
16th Dec 202510:16 amRNSAdditional Listing
2nd Dec 20259:12 amRNSTotal Voting Rights
25th Nov 20254:14 pmRNSHolding(s) in Company
12th Nov 20254:07 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:58 amRNSTotal Voting Rights
20th Oct 202511:24 amRNSBlock listing Interim Review
20th Oct 20259:32 amRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSTrading Update and Outlook for 2025
1st Oct 20259:05 amRNSTotal Voting Rights
1st Sep 20258:59 amRNSTotal Voting Rights
4th Aug 20253:09 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults For the Half Year (HY) Ended 30 June 2025
18th Jul 20258:40 amRNSHolding(s) in Company
1st Jul 20259:34 amRNSTotal Voting Rights
25th Jun 20258:47 amRNSAdditional Listing
24th Jun 20257:00 amRNSNotice of Half Year Results
17th Jun 20257:00 amRNSTrading Update and Outlook for 2025
16th Jun 20251:55 pmRNSDirector/PDMR Shareholding
2nd Jun 20253:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.